Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
12.24 +0.265 / +2.21%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.24 +0.01 / +0.08%
 
Volume: 1.9K

Today’s Trading

Previous close11.98
Today’s open11.84
Day’s range11.61 - 12.43
Volume1,031,162
Average volume (3 months)1,266,792
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-43.96%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+1.72+4.30%
RPTPRaptor Pharmaceutica...-1.96-12.41%
ACORAcorda Therapeutics ...+0.39+1.22%
SRPTSarepta Therapeutics...-0.24-0.80%
Data as of 3:59pm ET, 07/06/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers